143 related articles for article (PubMed ID: 7017048)
21. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
22. Cerebrotendinous xanthomatosis.
Grundy SM
N Engl J Med; 1984 Dec; 311(26):1694-5. PubMed ID: 6504107
[No Abstract] [Full Text] [Related]
23. Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis.
Tint GS; Salen G
J Lipid Res; 1982 May; 23(4):597-603. PubMed ID: 7097124
[TBL] [Abstract][Full Text] [Related]
24. Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3 beta,7 alpha-diol: localization of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase in pig tissues and subcellular fractions.
Furster C
Biochim Biophys Acta; 1999 Jan; 1436(3):343-53. PubMed ID: 9989265
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis of chenodeoxycholic acid: side-chain hydroxylation of 5 beta-cholestane-3 alpha, 7 alpha-diol by subcellular fractions of guinea pig liver.
Hoshita N; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS; Salen G; Mosbach EH
Lipids; 1978 Dec; 13(12):961-5. PubMed ID: 750834
[TBL] [Abstract][Full Text] [Related]
26. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
Batta AK; Shefer S; Batta M; Salen G
J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
[TBL] [Abstract][Full Text] [Related]
27. Determination of 7 alpha-hydroxy-4-cholesten-3-one level in plasma using isotope-dilution mass spectrometry and monitoring its circadian rhythm in human as an index of bile acid biosynthesis.
Yoshida T; Honda A; Tanaka N; Matsuzaki Y; Shoda J; He B; Osuga T; Miyazaki H
J Chromatogr B Biomed Appl; 1994 May; 655(2):179-87. PubMed ID: 8081463
[TBL] [Abstract][Full Text] [Related]
28. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
29. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
[TBL] [Abstract][Full Text] [Related]
30. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
Norlin M; von Bahr S; Bjorkhem I; Wikvall K
J Lipid Res; 2003 Aug; 44(8):1515-22. PubMed ID: 12777473
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
Dayal B; Tint GS; Toome V; Batta AK; Shefer S; Salen G
J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722
[TBL] [Abstract][Full Text] [Related]
32. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.
Javitt NB; Kok E; Cohen B; Burstein S
J Lipid Res; 1982 May; 23(4):627-30. PubMed ID: 7097127
[TBL] [Abstract][Full Text] [Related]
33. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
Wolthers BG; van der Molen JC; Walrecht H; Hesselmans LF
Clin Chim Acta; 1990 Dec; 193(3):113-8. PubMed ID: 2282689
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of potential precursors of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX).
Salen G; Shefer S; Mosbach EH; Hauser S; Cohen BI; Nicolau G
J Lipid Res; 1979 Jan; 20(1):22-30. PubMed ID: 438653
[TBL] [Abstract][Full Text] [Related]
35. The role of sterol carrier protein2 and other hepatic lipid-binding proteins in bile-acid biosynthesis.
Lidström-Olsson B; Wikvall K
Biochem J; 1986 Sep; 238(3):879-84. PubMed ID: 3800967
[TBL] [Abstract][Full Text] [Related]
36. Effect of biliary obstruction on 26-hydroxylation of C27-steroids in bile acid synthesis.
Gustafsson J
J Lipid Res; 1978 Feb; 19(2):237-43. PubMed ID: 632686
[TBL] [Abstract][Full Text] [Related]
37. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
Setoguchi T; Salen G; Tint GS; Mosbach EH
J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
[TBL] [Abstract][Full Text] [Related]
38. In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid.
Kase BF; Pedersen JI; Strandvik B; Björkhem I
J Clin Invest; 1985 Dec; 76(6):2393-402. PubMed ID: 4077985
[TBL] [Abstract][Full Text] [Related]
39. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
40. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
